Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Chinese Herbal Medicines|November 21, 2022
Integrating systematic pharmacology-based strategy and experimental validation to explore mechanism of Tripterygium glycoside on cholangiocyte-related liver injuryYajing Li, Sen Li, Xiaoyong Xue, et al.
Pharmacological Research|October 6, 2025
Mitochondrial damage-associated molecular patterns (mito-DAMPs): Determinants of hepatopathy progression and therapeutic implicationsRanyi Luo, Yun Yang, Yinhao Zhang, et al.
Micromachines|August 21, 2019
An RISC-V Processor with Area-Efficient Memristor-Based In-Memory Computing for Hash Algorithm in Blockchain ApplicationsXiaoyong Xue, Chenzedai Wang, Wenjun Liu, et al.
Journal of Hepatology|February 6, 2025
Hyodeoxycholic acid ameliorates cholestatic liver fibrosis by facilitating m6A-regulated expression of a novel anti-fibrotic target ETV4Xiaoyong Xue, Runping Liu, Yajie Cai, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 11, 2023
Inhibiting autophagy to boost antitumor immunity with tetramethylpyrazine-loaded and PD-L1-targeting liposomal nanoparticlesFei Zhou, Xiaojiaoyang Li, Kexin Jia, et al.
Journal of Ethnopharmacology|March 22, 2024
Si-Wu-Tang attenuates hepatocyte PANoptosis and M1 polarization of macrophages in non-alcoholic fatty liver disease by influencing the intercellular transfer of mtDNAZhi Ma, Kaihong Xie, Xiaoyong Xue, et al.
Micromachines|February 25, 2022
All-Electrical Control of Compact SOT-MRAM: Toward Highly Efficient and Reliable Non-Volatile In-Memory ComputingHuai Lin, Xi Luo, Long Liu, et al.
Chinese Medicine|November 5, 2021
Si-Wu-Tang ameliorates fibrotic liver injury via modulating intestinal microbiota and bile acid homeostasisXiaoyong Xue, Jianzhi Wu, Mingning Ding, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 22, 2022
Si-Wu-Tang ameliorates bile duct ligation-induced liver fibrosis via modulating immune environmentZhi Ma, Xiaoyong Xue, Jinzhao Bai, et al.
Chinese Medicine|June 6, 2024
Si-Wu-Tang alleviates metabolic dysfunction-associated fatty liver disease by inhibiting ACSL4-mediated arachidonic acid metabolism and ferroptosis in MCD diet-fed miceXiaoyong Xue, Le Wang, Ruiyu Wu, et al.
Pageof 3